Biovie Inc. SEC filings BIVIW
Biovie Inc. has 507 filings in SEC EDGAR's recent list, going back to Jul 2, 2013. Its latest annual report, Form 10-K, was filed on Aug 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 11, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| DEF 14A | Proxy statement | Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 14, 2026 | Sep 11, 2026 |
| 424B5 | Prospectus supplement | Sep 14, 2026 | — |
| S-1/A | Amended registration statement | Aug 14, 2026 | — |
| 10-K | Annual report | Aug 13, 2026 | Jun 30, 2026 |
| FWP | Free writing prospectus | Aug 7, 2026 | — |
| FWP | Free writing prospectus | Aug 6, 2026 | — |
| FWP | Free writing prospectus | Aug 6, 2026 | — |
| S-1/A | Amended registration statement | Aug 6, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| S-1/A | Amended registration statement | Jul 31, 2026 | — |
| S-1 | Registration statement | Jul 17, 2026 | — |
| EFFECT | Filing | Jun 29, 2026 | — |
| S-3 | Shelf registration | Jun 18, 2026 | — |
| DRS | Filing | Jun 11, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 6, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | Nov 25, 2025 | — |
| EFFECT | Filing | Nov 18, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 13, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 12, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| POS AM | Filing | Oct 6, 2025 | — |
| POS EX | Filing | Oct 6, 2025 | — |
| 424B3 | Prospectus | Oct 6, 2025 | — |
| DEF 14A | Proxy statement | Sep 25, 2025 | Sep 25, 2025 |
| 10-K | Annual report | Aug 15, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 11, 2025 | Aug 7, 2025 |
| 424B5 | Prospectus supplement | Aug 8, 2025 | — |
| EFFECT | Filing | Aug 7, 2025 | — |
| CERT | Filing | Aug 7, 2025 | — |
| 8-A12B | Form 8-a12b | Aug 7, 2025 | — |
| CORRESP | Letter to the SEC | Aug 4, 2025 | — |
| CORRESP | Letter to the SEC | Aug 4, 2025 | — |
| S-1/A | Amended registration statement | Aug 4, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 23, 2025 | Jul 17, 2025 |
| CORRESP | Letter to the SEC | Jul 22, 2025 | — |
| CORRESP | Letter to the SEC | Jul 22, 2025 | — |
| S-1/A | Amended registration statement | Jul 22, 2025 | — |
| S-1/A | Amended registration statement | Jul 11, 2025 | — |
| S-1 | Registration statement | Jul 3, 2025 | — |
| 8-K |
Current report
Change to shareholder rights
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2025 | Jun 23, 2025 |
| DEF 14A | Proxy statement | Jun 2, 2025 | Jun 2, 2025 |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| DRS | Filing | May 15, 2025 | — |
| DRSLTR | Filing | May 14, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| PRE 14A | Preliminary proxy statement | May 8, 2025 | May 8, 2025 |
| PRE 14C | Filing | May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2025 | Mar 28, 2025 |
| 10-Q | Quarterly report | Feb 11, 2025 | Dec 31, 2024 |
| 1-A | Filing | Dec 31, 2024 | — |
| EFFECT | Filing | Dec 2, 2024 | — |
| 424B3 | Prospectus | Dec 2, 2024 | — |
| CORRESP | Letter to the SEC | Nov 29, 2024 | — |
| S-1/A | Amended registration statement | Nov 27, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2024 | — |
| S-8 | Employee stock plan registration | Nov 22, 2024 | — |
| S-1 | Registration statement | Nov 21, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 8, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 29, 2024 | Oct 28, 2024 |
| 424B5 | Prospectus supplement | Oct 29, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 29, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 23, 2024 |
| 424B5 | Prospectus supplement | Oct 24, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 24, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 22, 2024 | Oct 22, 2024 |
| 424B5 | Prospectus supplement | Oct 22, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 22, 2024 | Oct 21, 2024 |
| DEFA14A | Additional proxy material | Oct 22, 2024 | — |
| 10-K | Annual report | Sep 30, 2024 | Jun 30, 2024 |
| DEF 14A | Proxy statement | Sep 27, 2024 | Sep 27, 2024 |
| 424B5 | Prospectus supplement | Sep 25, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 25, 2024 | Sep 25, 2024 |
| 424B5 | Prospectus supplement | Sep 24, 2024 | — |
| 8-K/A | Amended current report | Sep 24, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 24, 2024 | Sep 23, 2024 |
| 424B5 | Prospectus supplement | Sep 23, 2024 | — |
| PRE 14A | Preliminary proxy statement | Sep 17, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Other events
|
Aug 21, 2024 | Aug 20, 2024 |
| 8-K/A |
Amended current report
Change to shareholder rights, Bylaw or fiscal year change
|
Aug 6, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Aug 1, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2024 | Jul 25, 2024 |
| DEF 14A | Proxy statement | Jun 17, 2024 | Jun 17, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 7, 2024 | Jun 7, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 19, 2024 | Apr 18, 2024 |
| UPLOAD | Letter from the SEC | Apr 5, 2024 | — |
| CORRESP | Letter to the SEC | Mar 15, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 6, 2024 | Mar 6, 2024 |
| 8-K/A | Amended current report | Mar 4, 2024 | Mar 4, 2024 |
| 424B5 | Prospectus supplement | Mar 4, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 1, 2024 | Mar 1, 2024 |
| 10-Q | Quarterly report | Feb 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Jan 25, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Other events
|
Jan 19, 2024 | Jan 19, 2024 |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 29, 2023 | Nov 29, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Nov 13, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 25, 2023 | Oct 25, 2023 |
| DEF 14A | Proxy statement | Sep 29, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 8, 2023 |
| 424B3 | Prospectus | Aug 29, 2023 | — |
| EFFECT | Filing | Aug 28, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2023 | — |
| CORRESP | Letter to the SEC | Aug 24, 2023 | — |
| S-3 | Shelf registration | Aug 18, 2023 | — |
| 10-K | Annual report | Aug 16, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 424B3 | Prospectus | Apr 14, 2023 | — |
| EFFECT | Filing | Apr 10, 2023 | — |
| CORRESP | Letter to the SEC | Apr 7, 2023 | — |
| 424B5 | Prospectus supplement | Apr 7, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 7, 2023 | Apr 6, 2023 |
| UPLOAD | Letter from the SEC | Apr 6, 2023 | — |
| CORRESP | Letter to the SEC | Apr 6, 2023 | — |
| S-3 | Shelf registration | Mar 31, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 13, 2023 | Mar 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2023 | Mar 2, 2023 |
| 10-Q | Quarterly report | Feb 10, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Dec 23, 2022 | Dec 23, 2022 |
| 424B5 | Prospectus supplement | Dec 23, 2022 | — |
| 8-K |
Current report
Other events
|
Dec 15, 2022 | Dec 14, 2022 |
| 424B5 | Prospectus supplement | Dec 15, 2022 | — |
| RW | Filing | Dec 12, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 6, 2022 | Dec 5, 2022 |
| 8-K |
Current report
Other events
|
Dec 6, 2022 | Dec 6, 2022 |
| 424B5 | Prospectus supplement | Dec 6, 2022 | — |
| S-1 | Registration statement | Nov 10, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 10, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Oct 5, 2022 | Oct 4, 2022 |
| 424B5 | Prospectus supplement | Sep 30, 2022 | — |
| DEF 14A | Proxy statement | Sep 30, 2022 | Sep 30, 2022 |
| 10-K | Annual report | Sep 27, 2022 | Jun 30, 2022 |
| 8-K/A |
Amended current report
Regulation FD disclosure, Other events
|
Sep 7, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 7, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Material agreement
|
Aug 31, 2022 | Aug 31, 2022 |
| 424B5 | Prospectus supplement | Aug 31, 2022 | — |
| D | Filing | Jul 25, 2022 | — |
| DEF 14C | Information statement | Jul 25, 2022 | Jul 25, 2022 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale
|
Jul 18, 2022 | Jul 15, 2022 |
| PRE 14C | Filing | Jul 15, 2022 | Jul 15, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 15, 2022 | Jul 15, 2022 |
| 8-K |
Current report
New debt, Regulation FD disclosure
|
Jun 29, 2022 | Jun 28, 2022 |
| 10-Q | Quarterly report | May 11, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Feb 8, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Dec 1, 2021 | Nov 30, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2021 | Oct 13, 2021 |
| S-8 | Employee stock plan registration | Oct 4, 2021 | — |
| DEF 14A | Proxy statement | Sep 14, 2021 | Sep 13, 2021 |
| 10-K | Annual report | Aug 30, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Aug 11, 2021 | Aug 8, 2021 |
| 424B5 | Prospectus supplement | Aug 10, 2021 | — |
| FWP | Free writing prospectus | Aug 6, 2021 | — |
| 424B5 | Prospectus supplement | Aug 6, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Jun 11, 2021 | Jun 10, 2021 |
| DEFM14C | Filing | May 20, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2021 | May 17, 2021 |
| PRER14C | Pre 14c | May 10, 2021 | — |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 10, 2021 | May 9, 2021 |
| PREM14C | Pre 14c | May 4, 2021 | May 4, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 29, 2021 | Apr 28, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Apr 27, 2021 | Apr 27, 2021 |
| EFFECT | Filing | Feb 2, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| 10-Q | Quarterly report | Jan 29, 2021 | Dec 31, 2020 |
| UPLOAD | Letter from the SEC | Jan 29, 2021 | — |
| S-3 | Shelf registration | Jan 22, 2021 | — |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Sep 23, 2020 | Sep 23, 2020 |
| UPLOAD | Letter from the SEC | Sep 18, 2020 | — |
| 424B4 | Prospectus | Sep 18, 2020 | — |
| EFFECT | Filing | Sep 17, 2020 | — |
| S-1MEF | Filing | Sep 17, 2020 | — |
| CERT | Filing | Sep 17, 2020 | — |
| CORRESP | Letter to the SEC | Sep 16, 2020 | — |
| CORRESP | Letter to the SEC | Sep 16, 2020 | — |
| S-1/A | Amended registration statement | Sep 8, 2020 | — |
| 8-A12B | Filing | Aug 25, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2020 | — |
| S-1/A | Amended registration statement | Aug 21, 2020 | — |
| 10-K/A | Amended annual report | Aug 7, 2020 | Jun 30, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIVI (Nasdaq), BIVIW (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Carson City, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1580149
- Former names
- NANOANTIBIOTICS, INC. (until Jul 22, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.